Ninlaro Capsule
Product Images NDC 63020-400

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ninlaro (NDC 63020-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ninlaro 01)

FDA Label Image

Figure 1 (Ninlaro 02)

FDA Label Image

Principal Display Panel (4 mg Capsule Blister Pack)

Principal Display Panel (4 mg Capsule Blister Pack)
NINLARO® is a medication that comes in capsule form and has the NDC code 63020-400-01. The package insert should be read before using. The rest of the text is not available as it contains non-English characters and errors.*
FDA Label Image

Principal Display Panel (3 mg Capsule Blister Pack)

Principal Display Panel (3 mg Capsule Blister Pack)
The text appears to be a mix of product information, addresses, and symbols. It is not possible to generate a useful description from this text.*
FDA Label Image

Principal Display Panel (2.3 mg Capsule Blister Pack)

Principal Display Panel (2.3 mg Capsule Blister Pack)
NDC 63020-230-01 is a package of © NINLARO (ixazomib) capsules with 1 capsule inside. The package insert should be read before use. The rest of the text appears to be gibberish and is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.